Copaxone
Jul 18, 2014
Compare the Global Sales of Blockbuster Drugs Losing Patent in 2014
Compare the global sales of 2013 and 2012 of the top ten blockbuster drugs which is losing patent this year. Teva Pharmaceutical's Copaxone is the most affected drugs in terms of sales as the sales of 2013 has increased to 4.328 billions bearing the highest loss. Least affected Drug is AbbVie's Trilipix which has f...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
